Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Factor

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|April 7, 2000
Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's diseaseJ H Friedman, S A Factor
Movement Disorders : Official Journal of the Movement Disorder Society|December 17, 1997
Adult-onset tics associated with peripheral injuryS A Factor, E S Molho
Experimental Neurology|January 1, 1995
Peripheral catecholamine output in Parkinson's disease: effects of drug treatmentS A Factor, A S Schneider
Southern Medical Journal|May 1, 1991
Persistent extrapyramidal syndrome with dystonia and rigidity caused by combined metoclopramide and prochlorperazine therapyS A Factor, M K Matthews
Movement Disorders : Official Journal of the Movement Disorder Society|September 26, 1997
Mosaic pattern of gliosis in the neostriatum of a North American man with craniocervical dystonia and parkinsonismS A Factor, K D Barron
The American Journal of Emergency Medicine|April 6, 2000
Emergency department presentations of patients with Parkinson's diseaseS A Factor, E S Molho
Movement Disorders : Official Journal of the Movement Disorder Society|May 29, 1999
Transient benefit of amantadine in Parkinson's disease: the facts about the mythS A Factor, E S Molho
Movement Disorders : Official Journal of the Movement Disorder Society|April 1, 1993
Basal ganglia infarction as a possible cause of cervical dystoniaE S Molho, S A Factor
New York State Journal of Medicine|March 1, 1987
Ethylene glycol intoxication: a new stage in the clinical syndromeS A Factor, N S Lava
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 1993
Early combination therapy with bromocriptine and levodopa in Parkinson's diseaseS A Factor, W J Weiner
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
Movement Disorders : Official Journal of the Movement Disorder Society|April 7, 2000
Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's diseaseJ H Friedman, S A Factor
Movement Disorders : Official Journal of the Movement Disorder Society|December 17, 1997
Adult-onset tics associated with peripheral injuryS A Factor, E S Molho
Experimental Neurology|January 1, 1995
Peripheral catecholamine output in Parkinson's disease: effects of drug treatmentS A Factor, A S Schneider
Southern Medical Journal|May 1, 1991
Persistent extrapyramidal syndrome with dystonia and rigidity caused by combined metoclopramide and prochlorperazine therapyS A Factor, M K Matthews
Movement Disorders : Official Journal of the Movement Disorder Society|September 26, 1997
Mosaic pattern of gliosis in the neostriatum of a North American man with craniocervical dystonia and parkinsonismS A Factor, K D Barron
The American Journal of Emergency Medicine|April 6, 2000
Emergency department presentations of patients with Parkinson's diseaseS A Factor, E S Molho
Movement Disorders : Official Journal of the Movement Disorder Society|May 29, 1999
Transient benefit of amantadine in Parkinson's disease: the facts about the mythS A Factor, E S Molho
Movement Disorders : Official Journal of the Movement Disorder Society|April 1, 1993
Basal ganglia infarction as a possible cause of cervical dystoniaE S Molho, S A Factor
New York State Journal of Medicine|March 1, 1987
Ethylene glycol intoxication: a new stage in the clinical syndromeS A Factor, N S Lava
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 1993
Early combination therapy with bromocriptine and levodopa in Parkinson's diseaseS A Factor, W J Weiner
Pageof 8